and subsequent combination with Special Phage Services in 2012, is a biotechnology company dedicated to the development of innovative antibacterial solutions to improve human and animal health through the application of its proprietary bacteriophage
the contract is to develop a chemical carrier of bacteriophages
to their external use in infections associated with diabetic foot ulcers and to identify the biological and genetic phage typed as components of the product (25 bacteriophages
mainly from the family siphoviridae and myoviridae).
Other potentially fatal pathogens are Salmonella, Campylobacter and E-coli, for which EBI Food Safety is also developing bacteriophage
The virus cream is the latest example of a resurrection of interest in bacteriophages
, or "phages" - viruses which destroy bacteria but appear to be harmless to humans.
In the fight against Listeria, one of the most dangerous food pathogens, US food processing companies can now apply a novel yet natural tool: ListexTM bacteriophages
isolates selective for virtually any antibiotic-resistant bacteria can be developed.
In this issue, Stocher and Berg (8) added value to this control by packaging the control sequence in bacteriophage
8] cfu/mL) and spiked with tracer solution containing bacteriophage
An anthrax-specific bacteriophage
produces a protein--a lysin--that kills anthrax bacteria by destroying their cell walls from the outside, the researchers said.
EBI Food Safety is a privately held Life Sciences company, focused on the development and commercialization of new anti-bacterial agents, based on its bacteriophage
This will reinforce EBI Food Safety's position as product leader in the field of applied bacteriophage
technology and marks a breakthrough in the fight against dangerous bacteria", says EBI Food Safety's CEO Mark Offerhaus.
A protein made by an anthrax-specific bacteriophage
kills the bacteria by destroying the cell walls, researchers from Rockefeller University, New York City said in a letter to Nature.
In an animal model of acute infection with Pseudomonas aeruginosa anovel therapy comprising a tailored mix of bacteriophage
is able to clear respiratory tract infection with efficacy comparable or superior to high dose antibiotics known to be effective in this model (ciprofloxacin)
is a virus that infects and replicates within bacteria.
The virus, called M13 bacteriophage
, consists of an outer coat of protein surrounding an inner core of genes.